These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 32436685)

  • 21. Design of the POINT study: Pharmacotherapy Optimisation through Integration of a Non-dispensing pharmacist in a primary care Team (POINT).
    Hazen AC; Sloeserwij VM; Zwart DL; de Bont AA; Bouvy ML; de Gier JJ; de Wit NJ; Leendertse AJ
    BMC Fam Pract; 2015 Jul; 16():76. PubMed ID: 26135582
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Assessing care team perspectives on integration of a community pharmacist into an ambulatory care practice.
    Riggins SR; Abode AM; Holland CR; Rhodes LA; Marciniak MW
    J Am Pharm Assoc (2003); 2019; 59(4S):S122-S128.e1. PubMed ID: 31231003
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prospective daily review of discharge medications by pharmacists: Effects on measures of safety and efficiency.
    Craynon R; Hager DR; Reed M; Pawola J; Rough SS
    Am J Health Syst Pharm; 2018 Oct; 75(19):1486-1492. PubMed ID: 29976829
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Integration of a primary healthcare pharmacist.
    Kolodziejak L; Rémillard A; Neubauer S
    J Interprof Care; 2010 May; 24(3):274-84. PubMed ID: 20388026
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Data-Driven Scheduling for Improving Patient Efficiency in Ophthalmology Clinics.
    Hribar MR; Huang AE; Goldstein IH; Reznick LG; Kuo A; Loh AR; Karr DJ; Wilson L; Chiang MF
    Ophthalmology; 2019 Mar; 126(3):347-354. PubMed ID: 30312629
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Integrating pharmacists into primary care teams: barriers and facilitators.
    Jorgenson D; Laubscher T; Lyons B; Palmer R
    Int J Pharm Pract; 2014 Aug; 22(4):292-9. PubMed ID: 24279947
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Changing relationships: attitudes and opinions of general practitioners and pharmacists regarding the role of the community pharmacist.
    Muijrers PE; Knottnerus JA; Sijbrandij J; Janknegt R; Grol RP
    Pharm World Sci; 2003 Oct; 25(5):235-41. PubMed ID: 14584231
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Impact of a pharmacist-driven beta-lactam allergy interview on inpatient antimicrobial therapy: A pilot project.
    Sigona NS; Steele JM; Miller CD
    J Am Pharm Assoc (2003); 2016; 56(6):665-669. PubMed ID: 27745795
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Implementation and evaluation of a team-based pharmacy practice model in a community health system.
    Gill TK; Thornton LM; Schroeder TR; Garrelts JC; Schminke BC; Utz KJ; Gerlach CT
    Am J Health Syst Pharm; 2019 Mar; 76(7):470-477. PubMed ID: 31415682
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacist-Physician Split-Shared Visits in a Federally Qualified Health Center: Lessons Learned from a Novel Reimbursement Model using Telehealth.
    Abou-Karam NM; Jump ME; Jiao J; Schmelz AN
    Innov Pharm; 2022; 13(1):. PubMed ID: 36304686
    [No Abstract]   [Full Text] [Related]  

  • 31. Primary Care Teams and Pharmacist Staffing Ratios: Is There a Magic Number?
    Smith MA
    Ann Pharmacother; 2018 Mar; 52(3):290-294. PubMed ID: 29020794
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Primary Care Provider Perceptions of Pharmacist Services in an Urban, Safety Net Health System.
    McNamara A; Chan LLS; Wong SL
    J Pharm Pract; 2020 Dec; 33(6):790-798. PubMed ID: 30979341
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Reducing unnecessary hospital readmissions: the pharmacist's role in care transitions.
    Novak CJ; Hastanan S; Moradi M; Terry DF
    Consult Pharm; 2012 Mar; 27(3):174-9. PubMed ID: 22421517
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Assessing the impact of clinical pharmacists on naloxone coprescribing in the primary care setting.
    Watson A; Guay K; Ribis D
    Am J Health Syst Pharm; 2020 Mar; 77(7):568-573. PubMed ID: 32207821
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacist's identity development within multidisciplinary primary health care teams in Ontario; qualitative results from the IMPACT project.
    Pottie K; Haydt S; Farrell B; Kennie N; Sellors C; Martin C; Dolovich L;
    Res Social Adm Pharm; 2009 Dec; 5(4):319-26. PubMed ID: 19962675
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Appointment standardization evaluation in a primary care facility.
    Huang YL
    Int J Health Care Qual Assur; 2016 Jul; 29(6):675-86. PubMed ID: 27298064
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Transition of care to prevent recurrence after acute coronary syndrome: the critical role of the primary care provider and pharmacist.
    Goldman JD; Harte FM
    Postgrad Med; 2020 Jun; 132(5):426-432. PubMed ID: 32207352
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Impact of pharmacists' interventions on the pharmacotherapy of patients with complex needs monitored in multidisciplinary primary care teams.
    Samir Abdin M; Grenier-Gosselin L; Guénette L
    Int J Pharm Pract; 2020 Feb; 28(1):75-83. PubMed ID: 31468599
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Anticoagulation clinic workflow analysis.
    Vazquez SR; Campbell J; Hamann G; George C; Sprabery L
    J Am Pharm Assoc (2003); 2009; 49(1):78-85. PubMed ID: 19196602
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Factors influencing the acceptance of referrals for clinical pharmacist managed disease states in primary care.
    Bhat S; Kroehl M; Yi WM; Jaeger J; Thompson AM; Lam HM; Loeb D; Trinkley KE
    J Am Pharm Assoc (2003); 2019; 59(3):336-342. PubMed ID: 30948239
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.